To Study The Effect Of Raktapradarnashak Yog In Heavy Menstrual Bleeding

A Randomised Controlled Clinical Trial To Study The Effect Of Raktapradarnashak yog In Asrigdara With Special Reference To Functional Abnormal Uterine Bleeding. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088321

Enrollment

Registered

2025-06-05

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients complaining symptoms of Asrigdara such as excessive and prolonged uterine bleeding with PBAC score more than equal to 150. 2. Female patients with age group 18 years to 45 years. 3. Patients having excessive p/v bleeding due to ovulatory

Exclusion criteria

Exclusion criteria: 1.Patients with Systemic Hemorrhagic Disorders. 2. Patients with Structural abnormalities like Uterine Polyps,Endometriosis, Uterine Erosions, Uterine Fibroids, Ovarian mass, Malignancy of Uterus or Cervix, etc. 3. Postdelivery bleeding, Post MTP bleeding, Post D and C bleeding. 4. Patients with Intra Uterine Contraceptive Device. 5. Injuries to Reproductive tract. 6. Systemic disorders like, Diabetes Mellitus, Severe anemia

Design outcomes

Primary

Measure	Time frame
Reduction of symptoms of asrigdara after administration of Raktapradarnashak yogTimepoint: 28 days	—

Secondary

Measure	Time frame
When trial group stands in comparison with campare groupTimepoint: 18months	—

Countries

India

Contacts

Public ContactDr Pradnya Prataprao Deshmukh

SMBT Ayurved College and Hospital Dhamangaon Nashik

drpradnya2013@gmail.com9766310638

Outcome results